SBI Life Insurance
Market cap ₹1.65 L Cr
- P/E
- 63.27
- Day range
- ₹1,607.70 – ₹1,651.10
- 52-week range
- ₹1,607.70 – ₹2,132.00
- Volume
- 9.80 L
- Open
- ₹1,637.00
- Prev close
- ₹1,642.90
Latest results · Q1 FY27(consolidated)Revenue ₹46,091 CrProfit ₹725 CrMargin 1.6%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
SBILIFE in NSE indices and F&O
F&O margin for one lot of SBILIFE (375 shares)Research profile
Composite 56 / 100Factor percentiles
Derived metrics
- Earn. yield
- 1.6%
- Graham no.
- ₹342.30
- vs Graham
- -79.1%
- ROE ÷ P/B
- 1.7%
- 12-1 mom.
- -3.3%
- Return / vol
- -0.47
- FCF yield
- 20.9%
Appears in 10 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 11 in Insurance| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Life Insurance CorpLICI | ₹2.41 L Cr | 8.03 | 2.73 | 37.8% | 35.0% | 6.0% | 0.00 | +6.8% |
| SBI Life InsuranceSBILIFE | ₹1.65 L Cr | 63.27 | 8.16 | 13.7% | 15.0% | 1.6% | 0.00 | +18.8% |
| HDFC Life InsuranceHDFCLIFE | ₹1.14 L Cr | 55.31 | 5.89 | 11.3% | 10.0% | 1.4% | 0.16 | +18.3% |
| ICICI Lombard GICICICIGI | ₹79,544 Cr | 31.27 | 4.33 | 17.8% | 22.0% | 15.0% | 0.00 | +19.7% |
| ICICI Prudential LifeICICIPRULI | ₹62,529 Cr | 35.59 | 4.66 | 12.6% | 10.0% | -24.0% | 0.19 | -79.7% |
| General Insurance Corporation of IndiaGICRE | ₹56,799 Cr | 6.40 | 0.76 | 14.6% | 17.0% | 14.0% | 0.00 | -1.5% |
| Max Financial ServicesMFSL | ₹41,804 Cr | 383.32 | 7.92 | 2.0% | 3.0% | 1.1% | 0.35 | +16.8% |
| Star Health InsuranceSTARHEALTH | ₹31,206 Cr | 37.04 | 4.11 | 7.6% | 10.0% | 14.0% | 0.06 | +13.2% |
| Sector median | ₹56,799 Cr | 36.89 | 4.33 | 11.3% | 10.0% | 2.3% | 0.06 | +13.2% |
Sector as classified in the tracked universe; medians use every tracked Insurance company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 3d agoHeadlines about SBI Life Insurance from the last two weeks in the financial press. Stories belong to their publishers; Parasram India does not endorse them.
Key metrics
- P/E (TTM)
- 63.3
- EPS (TTM)
- ₹25.93
- Price / Book
- 8.16
- ROE (FY26)
- 13.7%
- ROCE (latest year)
- 15%
- Dividend yield
- 0.16%
Moving averages (NSE)
- 20-day
- ₹1,692.96
- Price below
- 50-day
- ₹1,726.98
- Price below
- 200-day
- ₹1,859.61
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- FII
- DII
- Public
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28,805 | 39,033 | 36,255 | 34,654 | 40,302 | 18,862 | 23,071 | 38,996 | 23,115 | 46,133 | 4,071 | 46,337 |
| Expenses | 28,392 | 38,681 | 37,043 | 34,060 | 39,696 | 18,266 | 23,520 | 38,333 | 22,600 | 45,517 | 5,117 | 45,579 |
| Operating Profit | 413 | 352 | -788 | 594 | 606 | 596 | -449 | 664 | 516 | 615 | -1,046 | 757 |
| OPM % | 1.4% | 0.9% | -2.2% | 1.7% | 1.5% | 3.2% | -1.9% | 1.7% | 2.2% | 1.3% | -26% | 1.6% |
| Other Income | 12 | 18 | 1,639 | 3 | -4 | -3 | 1,350 | -8 | 16 | 27 | 1,913 | 36 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 424 | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 | 793 |
| Tax % | 10% | 13% | 5% | 13% | 12% | 7% | 10% | 9% | 7% | 10% | 7% | 9% |
| Net Profit | 380 | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 | 725 |
| EPS in Rs | ₹3.80 | ₹3.21 | ₹8.10 | ₹5.19 | ₹5.28 | ₹5.50 | ₹8.12 | ₹5.93 | ₹4.93 | ₹5.75 | ₹8.02 | ₹7.23 |
From company filings, updated 24 Oct 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
0 days since Mar 2021
0 days since Mar 2021
+3 days since Mar 2021
Strengths, risks & growth
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A. [1]
Strengths
- Company is almost debt free.
- Company is expected to give good quarter
Risks
- Stock is trading at 8.18 times its book value
- The company has delivered a poor sales growth of 6.52% over past five years.
- Tax rate seems low
- Earnings include an other income of Rs.1,991 Cr.
- Dividend payout has been low at 12.2% of profits over last 3 years
Compounded Sales Growth
- 10 Years
- +19%
- 5 Years
- +7%
- 3 Years
- +12%
- TTM
- -1%
Compounded Profit Growth
- 10 Years
- +11%
- 5 Years
- +11%
- 3 Years
- +13%
- TTM
- +5%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- +8%
- 3 Years
- +8%
- 1 Year
- -11%
Return on Equity
- 10 Years
- +15%
- 5 Years
- +14%
- 3 Years
- +14%
- Last Year
- +14%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 55.34% | 55.33% | 55.32% | 55.31% | -0.01 pp |
| FII | 21.88% | 21.51% | 20.95% | 20.68% | -0.27 pp |
| DII | 18.72% | 19.13% | 19.67% | 20.05% | +0.38 pp |
| Public | 4.05% | 4.02% | 4.06% | 3.94% | -0.12 pp |
Filed with NSE for Sept 2026: promoters 55.31%, public 44.69% · XBRL filing
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 15.77% (-0.10 pp)- Promoters55.3%
- Foreign institutions20.7%
- Mutual funds15.8%
- Insurance1.4%
- Other domestic institutions2.9%
- Retail1.8%
- Others2.2%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| HDFC Flexi Cap Fund | 2.12% | 3.25% | -0.22 pp |
| ICICI Pru Value Fund | 0.80% | 2.31% | +0.02 pp |
| ICICI Pru India Opp Fund | 0.66% | 3.02% | +0.11 pp |
| HDFC Balanced Advantage Fund | 0.54% | 0.88% | -0.00 pp |
| Mirae Asset Large & Midcap Fund | 0.52% | 2.03% | +0.06 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Parasram India.
Risk & trend
From 275 daily sessions to 23 Oct 2026.
Risk
- Volatility (1Y)
- 20.8%
- Downside volatility
- 21.0%
- Worst 5% of days
- 2.4%
- Average of that tail
- 3.1%
- Max drawdown (1Y)
- 22.3%
- Below its peak
- 22.3%
Against the market
- Beta vs Nifty 50
- 0.83
- Correlation
- 0.53
- Relative strength (3M)
- -6.2%
- ATR (14)
- 2.5%
Return
- Return 1M
- -6.6%
- Return 3M
- -11.5%
- Return 6M
- -13.0%
- Return 1Y
- -9.7%
- vs 200-day average
- -11.8%
Momentum
- RSI (14)
- 37.5
- MACD histogram
- -3.90
- Stochastic %K
- 22.0
- ADX (14)
- 40.7
- +DI / −DI
- 5.5 / 24.6
- Money flow index
- 42.0
Participation
- Delivery (20d avg)
- 59.3%
- vs its 60-day baseline
- -2.3 pts
- Volume vs 20-day
- -0.7σ
- Close vs day's VWAP
- +0.9%
- 52-week position
- 0 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Jun 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹34,338 Cr
- FCF yield
- 20.9%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Model simulation
30 independent runs of NeoQuasar/Kronos-small, conditioned on daily bars to 1 Oct 2026, simulating 10 sessions ahead.
Lower edge (10th percentile)
₹1,736.56
+0.9%
Upper edge (90th percentile)
₹1,802.43
+4.7%
The marker is the last close, ₹1,721.6. Eight of every ten simulated runs ended inside this range; the middle run ended at ₹1,773.14 (+3.0%), which is the centre of the simulation and not an expected or target price.
The model reads price history only. It has not seen this company's results, its filings, its industry or anything that happened after 1 Oct 2026. Ranges widen with horizon because the further out the simulation runs, the less the recent past constrains it.
Corporate actions
- dividend₹2.70
Interim Dividend - Rs 2.70 Per Share
6 Mar 2026ex-date - dividend₹2.70
Interim Dividend - Rs 2.70 Per Share
7 Mar 2025ex-date - dividend₹2.70
Interim Dividend - Rs 2.70 Per Share
15 Mar 2024ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Share
16 Mar 2023ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share
29 Mar 2022ex-date - dividend₹2.50
Interim Dividend - Rs 2.5 Per Share
5 Apr 2021ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share
3 Apr 2019ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share (Purpose Revised)
3 Apr 2018ex-date
Company announcements
The Company will be hosting an earnings conference call with analysts and investors at 19:00 (IST) on October 27, 2026 to update the performance of the Company for the half year ended September ....
SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve financial results ....
Please find enclosed certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
The Board Stakeholders' Relationship and Sustainability Committee vide its resolution dated October 07, 2026 has allotted 4,160 equity shares towards exercise of vested options. This intimate ....
Please find attached Intimation of closure of trading window as per SEBI (Prohibition of Insider Trading) Regulation, 2015
Please find attached intimation under Regulation 30 of SEBI LODR w.r.t. to order received from Deputy Commissioner, Jaipur, Rajasthan in relation to GST.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 and other applicable provisions, we hereby inform that the Board of Directors, basis recommendation of the Board Nomination ....
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, we hereby inform that the Board of Directors, ....
The Board Stakeholders' Relationship and Sustainability Committee vide its circular resolution dated September 17, 2026 has allotted equity shares towards exercise of vested options. This ....
Please find Intimation for appointment of Joint Statutory Auditors of the Company for FY 2026-27, as per regulation 30 of the SEBI (LODR) Regulations, 2015.
Please find attached Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
Please find attached Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
Please find attached Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
Pursuant to regulation 30 of SEBI (LODR) Regulations 2015, we wish to inform you that Mr. Narayan K Seshadri (DIN: 00053563) ceases to be an Independent Director of the Company upon completion ....
The Board Stakeholders' Relationship and Sustainability Committee vide its circular resolution dated August 18, 2026 has allotted equity shares towards exercise of vested options. This ....
Filed with BSE (scrip 540719); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Jul 2026TranscriptSlidesRecording
- Apr 2026TranscriptSlidesRecording
- Apr 2026Slides
- Feb 2026TranscriptSlides
- Oct 2025TranscriptSlidesRecording
- Jul 2025TranscriptSlides
Credit ratings
- Rating update · 4 May from crisil
- Rating update · 9 May 2025 from crisil
- Rating update · 10 May 2024 from crisil
- Rating update · 12 May 2023 from crisil
- Rating update · 12 Dec 2022 from crisil
- Rating update · 25 May 2022 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 24 Jul 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
SBI Life Insurance: common questions
Answered from the figures on this page.
